Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration
- PMID: 10216166
- DOI: 10.1016/s0005-2728(99)00011-0
Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration
Abstract
We recently reported the preferential accumulation of 8-hydroxydeoxyguanosine (8OHdG) adducts in cardiac mitochondrial DNA (mtDNA) following acute intoxication of rats with doxorubicin (C.M. Palmeira et al., Biochim. Biophys. Acta, 1321 (1997) 101-106). The concentration of 8OHdG adducts decreased to control values within 2 weeks. Since conventional antineoplastic therapy entails repeated administration of small doses of doxorubicin, it was of interest to characterize the kinetics for the accumulation and repair of 8OHdG adducts in the various DNA fractions. Weekly injections of doxorubicin (2 mg/kg, i.p.) to adult male Sprague-Dawley rats caused a cumulative dose-dependent increase in the concentration of 8OHdG adducts in both mtDNA and nuclear DNA (nDNA) from heart and liver. Following six weekly injections, the concentration of 8OHdG in cardiac mtDNA was 50% higher than liver mtDNA and twice that of cardiac nDNA. In contrast to the rapid repair of 8OHdG observed during the first days following an acute intoxicating dose of doxorubicin, the concentration of 8OHdG adducts remained constant between 1 and 5 weeks following the last injection. This was true for all DNA fractions examined. The cardioselective accumulation and persistence of 8OHdG adducts to mtDNA is consistent with the implication of mitochondrial dysfunction in the cumulative and irreversible cardiotoxicity observed clinically in patients receiving doxorubicin cancer chemotherapy.
Similar articles
-
Preferential oxidation of cardiac mitochondrial DNA following acute intoxication with doxorubicin.Biochim Biophys Acta. 1997 Aug 22;1321(2):101-6. doi: 10.1016/s0005-2728(97)00055-8. Biochim Biophys Acta. 1997. PMID: 9332499
-
Doxorubicin-induced persistent oxidative stress to cardiac myocytes.Toxicol Lett. 2001 May 19;121(3):151-7. doi: 10.1016/s0378-4274(01)00329-0. Toxicol Lett. 2001. PMID: 11369469
-
Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.Cancer Res. 2001 Jan 15;61(2):771-7. Cancer Res. 2001. PMID: 11212281
-
Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity.Toxicology. 2017 Sep 1;390:63-73. doi: 10.1016/j.tox.2017.08.011. Epub 2017 Sep 1. Toxicology. 2017. PMID: 28865727
-
Adducts to nuclear DNA and mitochondrial DNA as biomarkers in chemoprevention.IARC Sci Publ. 1996;(139):291-301. IARC Sci Publ. 1996. PMID: 8923039 Review.
Cited by
-
Mitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex Interplay.Cells. 2022 Jun 22;11(13):2000. doi: 10.3390/cells11132000. Cells. 2022. PMID: 35805084 Free PMC article. Review.
-
Membrane Lipid Replacement for reconstituting mitochondrial function and moderating cancer-related fatigue, pain and other symptoms while counteracting the adverse effects of cancer cytotoxic therapy.Clin Exp Metastasis. 2024 Jun;41(3):199-217. doi: 10.1007/s10585-024-10290-6. Epub 2024 Jun 16. Clin Exp Metastasis. 2024. PMID: 38879842 Review.
-
A novel quinone-based derivative (DTNQ-Pro) induces apoptotic death via modulation of heat shock protein expression in Caco-2 cells.Br J Pharmacol. 2010 Jun;160(4):931-40. doi: 10.1111/j.1476-5381.2010.00718.x. Br J Pharmacol. 2010. PMID: 20590589 Free PMC article.
-
Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy.Circ Res. 2020 Mar 27;126(7):926-941. doi: 10.1161/CIRCRESAHA.119.314681. Epub 2020 Mar 26. Circ Res. 2020. PMID: 32213135 Free PMC article. Review.
-
PRDX5 as a novel binding partner in Nrf2-mediated NSCLC progression under oxidative stress.Aging (Albany NY). 2020 Jan 3;12(1):122-137. doi: 10.18632/aging.102605. Epub 2020 Jan 3. Aging (Albany NY). 2020. PMID: 31899687 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources